Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.
Tracey M WeissDena Rosen RameyLingfeng YangXinyue LiuMahesh J PatelSwapnil RajpathakEdnan K BajwaDominik LautschPublished in: BMC pulmonary medicine (2022)
Patients with PH associated with COPD were identified in a US administrative claims database. Very few of these patients received any of the medications recommended for PAH, and only about two thirds received medications for COPD.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- pulmonary hypertension
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- pulmonary artery
- prognostic factors
- health insurance
- cystic fibrosis
- emergency department
- big data
- pulmonary arterial hypertension
- machine learning
- patient reported outcomes
- artificial intelligence
- deep learning
- data analysis